Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Experience of a Colombian center in the endovascular management of lifethreatening postpartum hemorrhage

Escobar MF, Velásquez JG, Holguín A, Sánchez J, Messa A, Carvajal JA, Nieto AJ.

Biomedica. 2019 Jun 15;39(2):314-322. doi: 10.7705/biomedica.v39i3.3837. English, Spanish.

2.

Utility Of POC Xpert HIV-1 Tests For Detection-Quantification Of Complex HIV Recombinants Using Dried Blood Spots From Kinshasa, D. R. Congo.

Rubio-Garrido M, Ndarabu A, Reina G, Barquín D, Fernández-Alonso M, Carlos S, Holguín Á.

Sci Rep. 2019 Apr 5;9(1):5679. doi: 10.1038/s41598-019-41963-y.

3.

Host Resistance, Genomics and Population Dynamics in a Salmonella Enteritidis and Phage System.

Holguín AV, Cárdenas P, Prada-Peñaranda C, Rabelo Leite L, Buitrago C, Clavijo V, Oliveira G, Leekitcharoenphon P, Møller Aarestrup F, Vives MJ.

Viruses. 2019 Feb 22;11(2). pii: E188. doi: 10.3390/v11020188.

4.

Prognostic factors in HIV-positive patients with non-Hodgkin lymphoma: a Peruvian experience.

Cuellar LE, Anampa-Guzmán A, Holguín AM, Velarde J, Portillo-Alvarez D, Zuñiga-Ninaquispe MA, Luna-Reyes ER, Vásquez J, Jeter JM, Winkfield KM.

Infect Agent Cancer. 2018 Jul 31;13:27. doi: 10.1186/s13027-018-0200-y. eCollection 2018.

5.

Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells.

Mencía Á, Chamorro C, Bonafont J, Duarte B, Holguin A, Illera N, Llames SG, Escámez MJ, Hausser I, Del Río M, Larcher F, Murillas R.

Mol Ther Nucleic Acids. 2018 Jun 1;11:68-78. doi: 10.1016/j.omtn.2018.01.009. Epub 2018 Jan 31.

6.

Tumor Biology as Predictor of Mortality in Liver Transplantation for Hepatocellular Carcinoma.

Caicedo LA, Delgado A, Duque M, Jiménez DF, Sepulveda M, García JA, Thomas LS, Garcia VH, Aristizabal AM, Gomez C, Arrunategui AM, Manzi E, Millan M, Villegas JI, Serrano O, Holguín A, Echeverri GJ.

Transplant Proc. 2018 Mar;50(2):485-492. doi: 10.1016/j.transproceed.2017.11.040.

PMID:
29579833
7.

Effect of HIV/HCV Co-Infection on the Protease Evolution of HIV-1B: A Pilot Study in a Pediatric Population.

Domínguez-Rodríguez S, Rojas P, Fernández McPhee C, Pagán I, Navarro ML, Ramos JT, Holguín Á.

Sci Rep. 2018 Feb 5;8(1):2347. doi: 10.1038/s41598-018-19312-2.

8.

Impact of Clinical Parameters in the Intrahost Evolution of HIV-1 Subtype B in Pediatric Patients: A Machine Learning Approach.

Rojas Sánchez P, Cobos A, Navaro M, Ramos JT, Pagán I, Holguín Á.

Genome Biol Evol. 2017 Oct 1;9(10):2715-2726. doi: 10.1093/gbe/evx193.

9.

Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis.

Rojas Sánchez P, Domínguez S, Jiménez De Ory S, Prieto L, Rojo P, Mellado P, Navarro M, Delgado R, Ramos JT, Holguín Á; Madrid Cohort of HIV-1 Infected Children and Adolescents Integrated in the Pediatric Branch of the Spanish National AIDS Network (CoRISPe).

Pediatr Infect Dis J. 2018 Mar;37(3):e48-e57. doi: 10.1097/INF.0000000000001760.

PMID:
28991889
10.

Pregnancy outcomes in perinatally HIV-infected young women in Madrid, Spain: 2000-2015.

Prieto LM, Fernández McPhee C, Rojas P, Mazariegos D, Muñoz E, Mellado MJ, Holguín Á, Navarro ML, González-Tomé MI, Ramos JT; Madrid Cohort of HIV-Infected Mother-Infant Pairs.

PLoS One. 2017 Aug 25;12(8):e0183558. doi: 10.1371/journal.pone.0183558. eCollection 2017.

11.

Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting.

Chacón L, Mateos ML, Holguín Á.

J Clin Virol. 2017 Jul;92:11-13. doi: 10.1016/j.jcv.2017.04.014. Epub 2017 Apr 26.

PMID:
28501753
12.

Impact of lopinavir-ritonavir exposure in HIV-1 infected children and adolescents in Madrid, Spain during 2000-2014.

Rojas Sánchez P, Prieto L, Jiménez De Ory S, Fernández Cooke E, Navarro ML, Ramos JT, Holguín Á; Madrid Cohort of HIV-1 Infected Children and Adolescents Integrated in the Paediatric Branch of the Spanish National AIDS Network (CoRISPe).

PLoS One. 2017 Mar 28;12(3):e0173168. doi: 10.1371/journal.pone.0173168. eCollection 2017.

13.

Clinical Determinants of HIV-1B Between-Host Evolution and their Association with Drug Resistance in Pediatric Patients.

Pagán I, Rojas P, Ramos JT, Holguín Á.

PLoS One. 2016 Dec 1;11(12):e0167383. doi: 10.1371/journal.pone.0167383. eCollection 2016.

14.

Biliary strictures complicating liver transplantation in pediatric patients: Experience in a South American transplant center.

Holguin AJ, Rodriguez-Takeuchi S, Ospina L, Acosta D, Botero V, Thomas L, Villegas J, Echeverry GJ, Caicedo L.

Clin Transplant. 2017 Feb;31(2). doi: 10.1111/ctr.12877.

PMID:
27888532
15.

HIV-1 Variants and Drug Resistance in Pregnant Women from Bata (Equatorial Guinea): 2012-2013.

Alvarez P, Fernández McPhee C, Prieto L, Martín L, Obiang J, Avedillo P, Vargas A, Rojo P, Benito A, Ramos JT, Holguín Á.

PLoS One. 2016 Oct 31;11(10):e0165333. doi: 10.1371/journal.pone.0165333. eCollection 2016.

16.

Evaluation of four commercial virological assays for early infant HIV-1 diagnosis using dried blood specimens.

Alvarez P, Prieto L, Martín L, Obiang J, Avedillo P, Vargas A, Rojo P, Fernández McPhee C, Sanz Canalejas L, Benito A, Ramos JT, Holguín Á.

Pediatr Res. 2017 Jan;81(1-1):80-87. doi: 10.1038/pr.2016.183. Epub 2016 Sep 21.

PMID:
27653084
17.

[Early diagnosis of human immunodeficiency virus-1 in infants: The prevention of mother-to-child transmission program in Equatorial Guinea].

Prieto-Tato LM, Vargas A, Álvarez P, Avedillo P, Nzi E, Abad C, Guillén S, Fernández-McPhee C, Ramos JT, Holguín Á, Rojo P, Obiang J.

Enferm Infecc Microbiol Clin. 2016 Nov;34(9):566-570. doi: 10.1016/j.eimc.2015.11.010. Epub 2016 Jan 8. Spanish.

PMID:
26778797
18.

Expansion of the E138A mutation in newly diagnosed HIV-infected patients in Gran Canaria.

Chamizo F, Gilarranz R, Tosco T, Carrillo D, Holguín Á, Santana É, Pérez-Arellano JL, Hernández M, Francés A, Cárdenes MÁ, Zarzalejos JM, Pena-López MJ.

Diagn Microbiol Infect Dis. 2016 Sep;86(1):58-60. doi: 10.1016/j.diagmicrobio.2016.06.014. Epub 2016 Jun 17.

PMID:
27352730
19.

Deep analysis of HIV-1 natural variability across HIV-1 variants at residues associated with integrase inhibitor (INI) resistance in INI-naive individuals.

Llácer Delicado T, Torrecilla E, Holguín Á.

J Antimicrob Chemother. 2016 Feb;71(2):362-6. doi: 10.1093/jac/dkv333. Epub 2015 Nov 5.

PMID:
26546669
20.

Phage ΦPan70, a Putative Temperate Phage, Controls Pseudomonas aeruginosa in Planktonic, Biofilm and Burn Mouse Model Assays.

Holguín AV, Rangel G, Clavijo V, Prada C, Mantilla M, Gomez MC, Kutter E, Taylor C, Fineran PC, Barrios AF, Vives MJ.

Viruses. 2015 Aug 12;7(8):4602-23. doi: 10.3390/v7082835.

21.

Description and consequences of prescribing off-label antiretrovirals in the Madrid Cohort of HIV-infected children over a quarter of a century (1988-2012).

Fernández-Cooke E, Rojas P, Holguin A, Tomé MI, Jimenez de Ory S, Mellado MJ, Navarro ML, Rojo P, Ramos JT.

Antivir Ther. 2016;21(1):65-70. doi: 10.3851/IMP2973. Epub 2015 Jun 16.

PMID:
26079937
22.

HIV-1 variability and viral load technique could lead to false positive HIV-1 detection and to erroneous viral quantification in infected specimens.

Alvarez P, Martín L, Prieto L, Obiang J, Vargas A, Avedillo P, Rojo P, Fernández McPhee C, Benito A, Ramos JT, Holguín Á.

J Infect. 2015 Sep;71(3):368-76. doi: 10.1016/j.jinf.2015.05.011. Epub 2015 May 29.

PMID:
26033694
23.

Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.

Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Kee PN, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HM, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW.

PLoS Med. 2015 Jun 1;12(6):e1001845. doi: 10.1371/journal.pmed.1001845. eCollection 2015 Jun. No abstract available.

24.

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.

Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, Rinke de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Ng KP, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HM, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW.

PLoS Med. 2015 Apr 7;12(4):e1001810. doi: 10.1371/journal.pmed.1001810. eCollection 2015 Apr. Erratum in: PLoS Med. 2015 Jun;12(6):e1001845.

25.

Molecular characterization of Salmonella paratyphi B dT+ and Salmonella Heidelberg from poultry and retail chicken meat in Colombia by pulsed-field gel electrophoresis.

Donado-Godoy P, Byrne BA, Hume M, León M, Pérez-Gutiérrez E, Vives Flores MJ, Clavijo V, Holguin Á, Romero-Zuñiga JJ, Castellanos R, Tafur M, Smith WA.

J Food Prot. 2015 Apr;78(4):802-7. doi: 10.4315/0362-028X.JFP-14-356.

PMID:
25836408
26.

Clinical and virologic follow-up in perinatally HIV-1-infected children and adolescents in Madrid with triple-class antiretroviral drug-resistant viruses.

Rojas Sánchez P, de Mulder M, Fernandez-Cooke E, Prieto L, Rojo P, Jiménez de Ory S, José Mellado M, Navarro M, Tomas Ramos J, Holguín Á; Madrid Cohort of HIV-Infected Children and Adolescents Integrated in the Paediatric Branch of the Spanish National AIDS Network (CoRISPe).

Clin Microbiol Infect. 2015 Jun;21(6):605.e1-9. doi: 10.1016/j.cmi.2015.02.003. Epub 2015 Feb 11.

27.

HIV-1 infection using dried blood spots can be confirmed by Bio-Rad Geenius™ HIV 1/2 confirmatory assay.

Fernández McPhee C, Álvarez P, Prieto L, Obiang J, Avedillo P, Vargas A, Rojo P, Abad C, Ramos JT, Holguín A.

J Clin Virol. 2015 Feb;63:66-9. doi: 10.1016/j.jcv.2014.12.018. Epub 2014 Dec 27.

PMID:
25600609
28.

Estimating the spatial and temporal distribution of species richness within Sequoia and Kings Canyon National Parks.

Wathen S, Thorne JH, Holguin A, Schwartz MW.

PLoS One. 2014 Dec 3;9(12):e112465. doi: 10.1371/journal.pone.0112465. eCollection 2014.

29.

Drug resistance in the HIV-1-infected paediatric population worldwide: a systematic review.

Rojas Sánchez P, Holguín A.

J Antimicrob Chemother. 2014 Aug;69(8):2032-42. doi: 10.1093/jac/dku104. Epub 2014 Apr 30. Review.

PMID:
24788658
30.

New findings in cleavage sites variability across groups, subtypes and recombinants of human immunodeficiency virus type 1.

Torrecilla E, Llácer Delicado T, Holguín Á.

PLoS One. 2014 Feb 7;9(2):e88099. doi: 10.1371/journal.pone.0088099. eCollection 2014.

31.

Different trends of transmitted HIV-1 drug resistance in Madrid, Spain, among risk groups in the last decade.

Yebra G, Delgado R, Pulido F, Rubio R, Galán JC, Moreno S, Holguín Á.

Arch Virol. 2014 May;159(5):1079-87. doi: 10.1007/s00705-013-1933-y. Epub 2013 Dec 3.

PMID:
24297490
32.

HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA.

de Mulder M, York VA, Wiznia AA, Michaud HA, Nixon DF, Holguin A, Rosenberg MG.

HIV Med. 2014 Mar;15(3):135-43. doi: 10.1111/hiv.12089. Epub 2013 Sep 25.

33.

Co-evolutionary dynamics of the bacteria Vibrio sp. CV1 and phages V1G, V1P1, and V1P2: implications for phage therapy.

Barbosa C, Venail P, Holguin AV, Vives MJ.

Microb Ecol. 2013 Nov;66(4):897-905. doi: 10.1007/s00248-013-0284-2. Epub 2013 Sep 8.

PMID:
24013213
34.

Reconstructing the timing and dispersion routes of HIV-1 subtype B epidemics in the Caribbean and Central America: a phylogenetic story.

Pagán I, Holguín A.

PLoS One. 2013 Jul 9;8(7):e69218. doi: 10.1371/journal.pone.0069218. Print 2013.

35.

Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.

Holguín Á, Yebra G, Martín L, de Pineda AT, Ruiz LE, Quezada AY, Nieto AI, Escobar G.

Clin Microbiol Infect. 2013 Dec;19(12):E523-32. doi: 10.1111/1469-0691.12264. Epub 2013 Jun 19.

36.

Dried blood as an alternative to plasma or serum for Trypanosoma cruzi IgG detection in screening programs.

Holguín A, Norman F, Martín L, Mateos ML, Chacón J, López-Vélez R, Pérez-Molina JA.

Clin Vaccine Immunol. 2013 Aug;20(8):1197-202. doi: 10.1128/CVI.00221-13. Epub 2013 Jun 5.

37.

Description of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in Spain.

Yebra G, de Mulder M, Holguín Á.

PLoS One. 2013 May 22;8(5):e64293. doi: 10.1371/journal.pone.0064293. Print 2013.

38.

The regenerative potential of fibroblasts in a new diabetes-induced delayed humanised wound healing model.

Martínez-Santamaría L, Conti CJ, Llames S, García E, Retamosa L, Holguín A, Illera N, Duarte B, Camblor L, Llaneza JM, Jorcano JL, Larcher F, Meana Á, Escámez MJ, Del Río M.

Exp Dermatol. 2013 Mar;22(3):195-201. doi: 10.1111/exd.12097.

PMID:
23489422
39.

Prevalence of primary resistance mutations to integrase inhibitors in treatment-naïve and -experienced patients infected with B and non-B HIV-1 variants.

Gutiérrez C, Hernández-Novoa B, Pérez-Elías MJ, Moreno AM, Holguín A, Dronda F, Casado JL, Moreno S.

HIV Clin Trials. 2013 Jan-Feb;14(1):10-6. doi: 10.1410/hct1401-10.

PMID:
23372110
40.

Phylogenetic and demographic characterization of HIV-1 transmission in Madrid, Spain.

Yebra G, Holguín A, Pillay D, Hué S.

Infect Genet Evol. 2013 Mar;14:232-9. doi: 10.1016/j.meegid.2012.12.006. Epub 2013 Jan 2.

PMID:
23291408
41.

High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.

de Mulder M, Yebra G, Navas A, de José MI, Gurbindo MD, González-Tomé MI, Mellado MJ, Saavedra-Lozano J, Muñoz-Fernández MÁ, de Ory SJ, Ramos JT, Holguín A; Madrid Cohort of HIV-Infected Children.

PLoS One. 2012;7(12):e52155. doi: 10.1371/journal.pone.0052155. Epub 2012 Dec 17.

42.

A humanized mouse model of HPV-associated pathology driven by E7 expression.

Buitrago-Pérez Á, Hachimi M, Dueñas M, Lloveras B, Santos A, Holguín A, Duarte B, Santiago JL, Akgül B, Rodríguez-Peralto JL, Storey A, Ribas C, Larcher F, del Rio M, Paramio JM, García-Escudero R.

PLoS One. 2012;7(7):e41743. doi: 10.1371/journal.pone.0041743. Epub 2012 Jul 23.

43.

Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.

de Mulder M, Yebra G, Navas A, Martin L, de Jose MI, Navarro ML, de Ory SJ, Gonzalez-Granado I, Mellado MJ, Ramos JT, Holguin A.

Pediatr Infect Dis J. 2012 Nov;31(11):e213-21. doi: 10.1097/INF.0b013e3182678c7c.

PMID:
22785049
44.

[Dried blood spots for monitoring HIV infection in Public Health Programs in developing countries].

De Mulder M, Holguín A.

Enferm Infecc Microbiol Clin. 2013 Feb;31(2):100-7. doi: 10.1016/j.eimc.2012.03.008. Epub 2012 May 4. Review. Spanish.

PMID:
22560588
45.

Implementing a cumulative supermatrix approach for a comprehensive phylogenetic study of the Teloschistales (Pezizomycotina, Ascomycota).

Gaya E, Högnabba F, Holguin A, Molnar K, Fernández-Brime S, Stenroos S, Arup U, Søchting U, Van den Boom P, Lücking R, Sipman HJ, Lutzoni F.

Mol Phylogenet Evol. 2012 May;63(2):374-87. doi: 10.1016/j.ympev.2012.01.012. Epub 2012 Jan 28.

PMID:
22306043
46.

Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses.

Yebra G, de Mulder M, Martín L, Rodríguez C, Labarga P, Viciana I, Berenguer J, Alemán MR, Pineda JA, García F, Holguín A; Cohort of the Spanish AIDS Research Network (CoRIS).

J Clin Microbiol. 2012 Feb;50(2):407-13. doi: 10.1128/JCM.05798-11. Epub 2011 Dec 7.

47.

Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population.

Yebra G, de Mulder M, Pérez-Elías MJ, Pérez-Molina JA, Galán JC, Llenas-García J, Moreno S, Holguín Á.

PLoS One. 2011;6(10):e26757. doi: 10.1371/journal.pone.0026757. Epub 2011 Oct 25.

48.

Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.

de Mulder M, Yebra G, Martín L, Prieto L, Mellado MJ, Rojo P, Muñoz-Fernández MÁ, Jiménez de Ory S, Ramos JT, Holguín A; Madrid cohort of HIV-infected children.

J Antimicrob Chemother. 2011 Oct;66(10):2362-71. doi: 10.1093/jac/dkr305. Epub 2011 Aug 2.

PMID:
21810838
49.

Molecular surveillance of HIV-1 in Madrid, Spain: a phylogeographic analysis.

González-Alba JM, Holguín A, Garcia R, García-Bujalance S, Alonso R, Suárez A, Delgado R, Cardeñoso L, González R, García-Bermejo I, Portero F, de Mendoza C, González-Candelas F, Galán JC.

J Virol. 2011 Oct;85(20):10755-63. doi: 10.1128/JVI.00454-11. Epub 2011 Jul 27.

50.

HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia.

Holguin A, Banda M, Willen EJ, Malama C, Chiyenu KO, Mudenda VC, Wood C.

AIDS Behav. 2011 Nov;15(8):1895-901. doi: 10.1007/s10461-011-9988-9.

Supplemental Content

Loading ...
Support Center